Revolution Medicines (RVMD)

Revolution Medicines (RVMD) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

RVMD rises without a confirmed company catalyst

Revolution Medicines rose 3.9% today, but no fresh company catalyst is established. The S&P 500 rose 0.2% today while the Nasdaq 100 fell 0.6%; investors can look to the company’s next clinical and earnings updates for new direction.

Published 2026-11-20 15:00:35 UTC.